ArticleThe Journal of allergy and clinical immunology2015
Mild B-cell lymphocytosis in patients with a CARD11 C49Y mutation.
Abstract readCase Reports
In one paragraph
Article in The Journal of allergy and clinical immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed.
- Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial.Cancer medicine · 2022Trial
- Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.Clinical and experimental immunology · 2026Article
- Potentiation of noncanonical NF-κB signaling and marginal zone B cell expansion by CARD11-mediated regulation of p100 processing.Cell reports · 2025Article
- QRICH1 mediates an intracellular checkpoint for CD8Science immunology · 2025Article
- Successful Treatment with Sirolimus of a Patient with a Novel CARD11 Germline Mutation in B-Cell Expansion with Nuclear Factor Kappa B and T-Cell Anergy: Case Report and Literature Review.Journal of clinical immunology · 2025Review
- Article
- Article
- CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma.Communications biology · 2022Article
- Article
- Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience.Frontiers in immunology · 2022Article
- A novel CARD11 germline mutation in a Chinese patient of B cell expansion with NF-κB and T cell anergy (BENTA) and literature review.Frontiers in immunology · 2022Review
- Article
- Inborn errors of immunity with atopic phenotypes: A practical guide for allergists.The World Allergy Organization journal · 2021Review
- Identification and Characterization of a Germline Mutation in CARD11 From a Chinese Case of B Cell Expansion With NF-κB and T Cell Anergy.Frontiers in immunology · 2021Article
- Monogenic Adult-Onset Inborn Errors of Immunity.Frontiers in immunology · 2021Review
- NF-κB: At the Borders of Autoimmunity and Inflammation.Frontiers in immunology · 2021Review
- Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study.Signal transduction and targeted therapy · 2020Review
- A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease.Journal of clinical immunology · 2020Article
- Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling.The Journal of biological chemistry · 2019Article
- Rare copy number variants in the genome of Chinese female children and adolescents with Turner syndrome.Bioscience reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
David BuchbinderDepartment of Hematology, Children's Hospital of Orange County, Orange, Calif; Department of Pediatrics, University of California at Irvine, Orange, Calif.
Jeffrey R StinsonDepartment of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Md.
Diane J NugentDepartment of Hematology, Children's Hospital of Orange County, Orange, Calif; Department of Pediatrics, University of California at Irvine, Orange, Calif.
Lucie HeurtierUniversité Paris Descartes, Sorbonne Paris Cité, Imagine Institute, Paris, France; INSERM UMR 1163, Human Lymphohematopoiesis Laboratory, Paris, France.
Felipe SuarezUniversité Paris Descartes, Sorbonne Paris Cité, Imagine Institute, Paris, France; Service d'Hématologie Adultes, Hôpital Necker-Enfants Malades, Paris, France.
Gauthaman SukumarDepartment of Anatomy, Physiology, & Genetics, Uniformed Services University of the Health Sciences, Bethesda, Md.
Clifton L DalgardDepartment of Anatomy, Physiology, & Genetics, Uniformed Services University of the Health Sciences, Bethesda, Md.
Cécile MassonBioinformatic Platform, Université Paris Descartes, Sorbonne Paris Cité, Imagine Institute, Paris, France.
Mélanie ParisotGenomic Core Facility, Université Paris Descartes, Sorbonne Paris Cité, Imagine Institute, Paris, France.
Yu ZhangLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
Helen F MatthewsLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
Helen C SuLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
Anne DurandyUniversité Paris Descartes, Sorbonne Paris Cité, Imagine Institute, Paris, France; INSERM UMR 1163, Human Lymphohematopoiesis Laboratory, Paris, France.
Alain FischerUniversité Paris Descartes, Sorbonne Paris Cité, Imagine Institute, Paris, France; INSERM UMR 1163, Human Lymphohematopoiesis Laboratory, Paris, France; Department of Pediatric Immunology, Hematology and Rheumatology, Hôpital Necker Enfants Malades, Paris, France; Collège de France, Paris, France.
Sven KrackerUniversité Paris Descartes, Sorbonne Paris Cité, Imagine Institute, Paris, France; INSERM UMR 1163, Human Lymphohematopoiesis Laboratory, Paris, France. Electronic address: sven.kracker@inserm.fr.
Andrew L SnowDepartment of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Md. Electronic address: andrew.snow@usuhs.edu.
Funding
Defining New Human Immunodeficiency and Immunodysregulation DisordersZIAAI001059 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SU, HELEN CHUN-HUI · 2009 to 2025
$20.5MMolecular Mechanisms of Familial Hemophagocytic LymphohistiocytosisZIAAI001058 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SU, HELEN · 2009 to 2013
$753kDefining New Human Immunodeficiency and Immunodysregulation DisordersZ01AI001059 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SU, HELEN · 2008 to 2008
$658kB Cell immunodeficiency in BENTA diseaseR21AI109187 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI SNOW, ANDREW L · 2014 to 2015
$412kEuropean Research Council 249816Intramural NIH HHS Z01 AI001059Intramural NIH HHS Z99 AI999999Intramural NIH HHS ZIA AI001058NIAID NIH HHS R21 AI109187
Abstract
PubMed holds no abstract for this paper.
Indexed as
Mutation, MissenseAdolescentB-LymphocytesCARD Signaling Adaptor ProteinsCell ProliferationDNA Mutational AnalysisFemaleGuanylate CyclaseHumansImmunologic MemoryLymphocytosisLymphoproliferative DisordersMaleMiddle AgedSeverity of Illness IndexCARD11 protein, humanCARD Signaling Adaptor ProteinsGuanylate Cyclase
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.